Children’s Place Retail Stores, Inc. (NASDAQ:PLCE) said Thursday that its first-quarter net income fell 29 percent from the year before, but its results still beat expectations. The company’s shares rose nearly 10 percent in premarket trading. Children’s Place Retail Stores, Inc. (NASDAQ:PLCE) stock opened today at $49.49 and is currently trading at $46.72. The stock showed a negative weekly performance of -4.85%.
Dollar Tree, Inc. (NASDAQ:DLTR), North America’s leading operator of discount variety stores selling everything for $1 or less, reported its results for the quarter ended May 3, 2014 (“first quarter”). Consolidated net sales for the first quarter were a record $2.00 billion, a 7.2% increase compared to $1.87 billion reported for the quarter ended May 4, 2013 (“first quarter 2013”). Dollar Tree, Inc. (NASDAQ:DLTR) stock opened at $53.92, in current trading session and currently is at $53.70, by gaining 7.40%. The 52 week range of $47.70 – $60.19. Company’s market capitalization is 11.10 billion.
Rediff.com India Limited (ADR) (NASDAQ:REDF), one of the premier news and online marketplaces in India, on 1 may announced that Rediffmail Enterprise, the Company’s business and professional email solution, has been selected as the 2014 CIO Choice Award winner in the Enterprise Email category through an independent voting survey conducted by the Centre of Recognition & Excellence.Rediff.com India Limited (ADR) (NASDAQ:REDF) stock is currently trading at $3.05. The EPS of the stock is -0.39. Company’s market capitalization is 84.15 million.
Shares of Dendreon (NASDAQ:DNDN) a biotech company that utilizes immunotherapeutic vaccines to treat cancer, soared as much as 14% after reporting additional data on Provenge, its advanced prostate cancer vaccine, at the American Urological Association’s annual meeting. Dendreon Corporation (NASDAQ:DNDN) stock opened the session at $2.17, and now is at $2.15. The 52 week range of the Dendreon Corporation (NASDAQ:DNDN) stock remained $1.81 – $5.38 and the day range was $2.15 – $2.18.
Isis Pharmaceuticals Inc. Inc. (NASDAQ:ISIS) said its experimental blood thinner was more effective than a commonly prescribed anticoagulant in patients undergoing total knee replacement surgery. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock opened today at $23.92 and is currently trading at $24.11. The stock showed a negative weekly performance of -8.88%.